Skip to main content

Month: September 2021

ABC arbitrage: 2021 Interim Results

ABC arbitrage 2021 Interim Results: €16.8m1 2021 annualized ROE: 21.7% The Board of Directors of ABC arbitrage, presided by the Chairman Dominique Ceolin, met on September 16, 2021 to approve the consolidated financial statements for the first half 2021.In EUR millions June 30, 2021 IFRS June 30, 2020 IFRS Dec. 31, 2020 IFRSNet revenues €35.1m €44.8m €68.8mNet income €16.8m €25.7m €35.1mEarnings per share (EPS) €0.29 €0.44 €0.60Annualized Return On Equity (ROE) 21.7% 32.8% 23.9%Business performance In accordance with IFRS standards, consolidated net revenue at 30 June 2021 was €35.1 million and consolidated net income amounted to €16.8 million, a decrease (-34.4%) compared to first half 2020, which was a historic half-year for the Group. After a fiscal year 2020 impacted by the...

Continue reading

Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock and Preferred Stock

WALTHAM, Mass., Sept. 21, 2021 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies, today announced the pricing of an underwritten public offering with gross proceeds of approximately $85.0 million. Viridian is selling a total of 6,185,454 shares of common stock at a public offering price of $11.00 per share and 23,126 shares of series B preferred stock (the “Series B Preferred”) at a public offering price of $733.37 per share, which are convertible into approximately 1,541,810 shares of common stock, subject to beneficial ownership conversion limits. In addition, Viridian has granted the underwriters a 30-day option to purchase an additional 1,159,089 shares of common stock at...

Continue reading

REPEAT – O2Gold Intercepts 20 g/t Au at the Main Aurora Vein, Which Has a Projected Extension of at Least 700 Meters, at Only 97 Meters of Depth

Figure 1Section C with AUR-21-001 sampling and results, as well as the trajectory of the completed AUR-21-003 holeFigure 2Drill cores of AUR-21-001 where it intercepted the main Aurora vein, showing 0.7m @ 20.11 g/t Au and 3.30 g/t Ag from 97.4 m.TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) — O2Gold Inc. (“O2Gold” or the “Company”) (TSXV: OTGO) is pleased to report high-grade gold-silver intercepts from its first drill hole at the Aurora Tunnel in Colombia, where the Company has exploitation and production permits. Key HighlightsHole AUR-21-001 targeted down-dip extensions of high-grade gold-silver mineralization indicated by rock chip sampling and prior artisanal production at the Aurora Tunnel. A mineralized interval was encountered (reported as downhole intervals) with the following results: 1.6...

Continue reading

Micro CHP Market to rise at CAGR of 23.45% through 2028 – Report by Market Research Future (MRFR)

New York, Sept. 21, 2021 (GLOBE NEWSWIRE) — Micro Combined Heat and Power Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Micro Combined Heat and Power Market Research Report, Type, Technology, Application and Region – Forecast till 2028” the market grow at a rate of 23.45% during the forecast period 2021-2028. Competitive Analysis List of the Key Companies Profiled in the Players involved in the Micro Combined Heat and Power Market Report are –Vaillant Group (Germany) Honda Power (Japan) Yanmar Holdings Co. Ltd. (Japan) Qnergy (US) Ceres Power Holdings PLC (UK) Aisin Group (Japan) Centrica plc (UK) BDR Thermea Group (UK) Mondragon Corporation (Spain) Dantherm Power (Denmark) Viessmann Group (Germany) Solid Power (US) Nucusa Energy (US) others.Get Free Sample...

Continue reading

Second Industry Body Updates Guidance for Use of PSMA PET Imaging

MELBOURNE, Australia and INDIANAPOLIS, Sept. 20, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) has today welcomed the Society of Nuclear Medicine and Molecular Imaging (SNMMI) updated Appropriate Use Criteria (AUC) for prostate specific membrane antigen (PSMA) positron emission tomography (PET) imaging. The updated AUC, developed following a critical review of evidence by leading experts to guide referring and imaging physicians on the appropriate use of imaging agents, recognise a widespread use of PSMA PET in men with prostate cancer including that PSMA PET-based imaging has a higher accuracy in the initial staging evaluation of men with newly diagnosed prostate cancer than conventional imaging (bone scan and CT). The AUC are based on scientific evidence and were developed collaboratively...

Continue reading

HUTCHMED Initiates SURTORI-01, a Phase III Trial of SULANDA® in Combination with TUOYI® in the Treatment of Advanced Neuroendocrine Carcinoma in China

HONG KONG and FLORHAM PARK, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that it has initiated SURTORI-01, a Phase III study to evaluate the efficacy and safety of surufatinib (SULANDA® in China) in combination with toripalimab compared with FOLFIRI to treat patients with advanced neuroendocrine carcinoma (“NEC”) who have progression of disease or intolerable toxicity after previous first-line chemotherapy. The first patient was dosed on September 18, 2021 in China. Toripalimab is marketed as TUOYI® in China by Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”). Professor Shen Lin, the lead principal investigator of the study and Vice President of Peking University Hospital and Cancer Institute, said: “There is a large unmet clinical need for...

Continue reading

Sabina Gold & Silver Announces Fully Subscribed Non-Brokered Private Placement Flow Through Financing to Raise Up to $13.75 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Sept. 20, 2021 (GLOBE NEWSWIRE) — Sabina Gold & Silver Corp (the “Company”) (SBB – TSX) is pleased to announce that it has arranged a fully subscribed non-brokered private placement (the “Financing’) pursuant to which it will sell approximately 7.3 million flow-through common shares (the “Flow-Through Common Shares”) at a price of $1.87 per share to raise gross proceeds of up to $13.75 million. “The proceeds from the sale of the Flow-Through Common Shares will be used primarily for continued advancement of the Umwelt underground exploration decline,” said Bruce McLeod, President & CEO. “This financing enables the Company to continue funding exploration initiatives while preserving hard dollars...

Continue reading

Bitcoin Well Retains Independent Trading Group (ITG) as Market Maker, Announces Issuance of Incentive Stock Options and Management Changes

EDMONTON, Alberta, Sept. 20, 2021 (GLOBE NEWSWIRE) — Bitcoin Well Inc. (TSXV: BTCW) (“Bitcoin Well” or the “Company”) is pleased to announce that we have retained Independent Trading Group Inc. (ITG) to provide market-making services in accordance with TSX Venture Exchange (“TSXV”) policies. In addition, Bitcoin Well has granted 300,565 incentive stock options (“Options”) to directors of the Company with an exercise price of $0.31 and a term of five years, expiring September 30, 2026. ITG RETAINED AS MARKET MAKER “By partnering with an established firm like Independent Trading Group, we are thrilled about the opportunity to enhance our liquidity and hopefully attract a broader investor base,” said Adam O’Brien, Founder and CEO of Bitcoin Well. “Having recently become the first publicly-traded bitcoin ATM company, we are committed...

Continue reading

Equity Bancshares, Inc. Initiates Quarterly Cash Dividend on Common Stock

WICHITA, Kan., Sept. 20, 2021 (GLOBE NEWSWIRE) — The Equity Bancshares, Inc. (NASDAQ: EQBK) Board of Directors (“Board”) announced it has initiated a quarterly cash dividend to its stockholders. The quarterly dividend of $0.08 per common share of Equity Bancshares, Inc. (“Equity” or “Company”) Class A stock is payable on October 14, 2021 to stockholders of record at the close of business on September 30, 2021. Future dividends will be subject to Board approval. “We’re pleased to declare a dividend to our stockholders for the first time in our Company’s history. We have been evaluating this as our Company and profits have each continued to grow,” said Brad Elliott, Chairman and CEO of Equity. “We appreciate the support of our stockholders and the ongoing efforts of our Equity Bank teams throughout our four-state footprint to continue...

Continue reading

Trigon Closes Oversubscribed Second Tranche of Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 20, 2021 (GLOBE NEWSWIRE) — Trigon Metals Inc. (TSX-V: TM) (“Trigon” or the “Company”) has closed, on an oversubscribed basis due to investor demand, a non-brokered second and final tranche (the “Second Tranche”) of its previously announced private placement of units (the “Offering”). The Company issued 7,562,500 units (the “Units”) pursuant to the Second Tranche at a price of $0.40 per Unit for aggregate gross proceeds of $3,025,000. Combined with the first tranche of the Offering, which closed earlier this month, the Company has issued a total of 17,165,000 Units in the Offering for aggregate gross proceeds of $6,866,000. Each Unit is comprised of one common share of Trigon (a “Share”) and one-half of one common share purchase...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.